Biolife Solutions (BLFS) Change in Accured Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Change in Accured Expenses data on file, last reported at $26000.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 62.5% year-over-year to $26000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 112.16% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 117.64% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $26000.0, down from $680000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for BLFS reached as high as $7.1 million in Q4 2024 and fell as low as -$2.8 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $610400.0 across 5 years, with a median of $43000.0 in 2023.
• On a YoY basis, Change in Accured Expenses climbed as much as 4516.28% in 2024 and fell as far as 14025.0% in 2024.
• Year by year, Change in Accured Expenses stood at $1.3 million in 2022, then surged by 175.06% to $3.7 million in 2023, then surged by 91.09% to $7.1 million in 2024, then slumped by 90.37% to $680000.0 in 2025, then sank by 96.18% to $26000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $26000.0 in Q1 2026, $680000.0 in Q4 2025, and -$1.8 million in Q3 2025.